Cargando…
Restoration of miR-23a expression by chidamide sensitizes CML cells to imatinib treatment with concomitant downregulation of CRYAB
MicroRNAs (miRNAs) are involved in various processes from the initiation and development of cancers, including chronic myeloid leukemia (CML). In this report, we aimed to investigate the roles of miR-23a in the regulation of imatinib mesylate (IM) sensitivity in CML cells and the possible mechanisms...
Autores principales: | Zhu, Xunxun, Zhang, Jingru, Sun, Yanping, Wang, Yan, Liu, Qian, Li, Peng, Yu, Shuang, Liu, Na, Ye, Jingjing, Ma, Daoxin, Ji, Chunyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162009/ https://www.ncbi.nlm.nih.gov/pubmed/35333695 http://dx.doi.org/10.1080/21655979.2022.2056322 |
Ejemplares similares
-
Early BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML alliance
por: Zhang, Jingru, et al.
Publicado: (2018) -
Reply: The long-term response to imatinib treatment of CML
por: Michor, F
Publicado: (2007) -
FZD7 regulates BMSCs-mediated protection of CML cells
por: Liu, Na, et al.
Publicado: (2015) -
Progression of the role of CRYAB in signaling pathways and cancers
por: Zhang, JunFei, et al.
Publicado: (2019) -
MATE1 regulates cellular uptake and sensitivity to imatinib in CML patients
por: Harrach, S, et al.
Publicado: (2016)